Pharmacokinetic and pharmacodynamic characterization of a new formulation containing synergistic proportions of interferons alpha-2b and gamma (HeberPAG®) in patients with mycosis fungoides: an open-label trial

Peer Review reports

Original Submission
2 May 2012	Submitted	Original manuscript
Resubmission - Version 2
	Submitted	Manuscript version 2
24 Aug 2012	Reviewed	Reviewer Report - Hidefumi Wada
7 Oct 2012	Reviewed	Reviewer Report - Mirte Malingre
29 Oct 2012	Author responded	Author comments - Idrian Garcia-Garcia
Resubmission - Version 3
29 Oct 2012	Submitted	Manuscript version 3
6 Dec 2012	Reviewed	Reviewer Report - Mirte Malingre
11 Dec 2012	Reviewed	Reviewer Report - Hidefumi Wada
Resubmission - Version 4
	Submitted	Manuscript version 4
Publishing
21 Dec 2012	Editorially accepted
28 Dec 2012	Article published	10.1186/2050-6511-13-20

Back to article page